Cav3.2 T-type calcium channnel inhibitors (Cavion)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCav3.2 T-type calcium channnel inhibitors (Cavion)
Drug Alias Namevoltage-dependent T-type calcium channel subunit alpha-1H inhibitors (Xdynia)Cav3.2 T-type calcium channnel inhibitors (Xdynia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-dependent T-type calcium channel subunit alpha-1H antagonists
TargetsVoltage-dependent T-type calcium channel subunit alpha-1H
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXdynia LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXdynia LLCCavion Inc
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A